Related Experiment Video

Updated: Aug 8, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Gene-directed enzyme prodrug therapy: a current assessment

Stephanie R McKeown1, Claire Ward, Tracy Robson

  • 1University of Ulster at Coleraine, Radiation Science Group, School of Biomedical Sciences, Centre for Molecular Biosciences, Cromore Road, Coleraine, Co Londonderry, Northern Ireland. S.R.McKeown@ulster.ac.uk

Current Opinion in Molecular Therapeutics
|October 8, 2004
PubMed

Insights

Gene-directed enzyme prodrug therapy uses gene delivery for tumor-specific enzyme activation of prodrugs into cancer-killing agents. This review examines current preclinical and clinical enzyme-prodrug combinations and discusses tumor targeting and bystander effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Gene-directed enzyme prodrug therapy (GDEPT) offers targeted cancer treatment.
  • It involves delivering a gene for a drug-metabolizing enzyme into tumor cells.
  • This enables localized conversion of a non-toxic prodrug to a potent cytotoxic agent.

Purpose of the Study:

  • To review current enzyme-prodrug combinations in GDEPT.
  • To discuss the challenges and advancements in tumor specificity.
  • To explore the potential of bystander effects for enhanced cytotoxicity.

Main Methods:

  • Literature review of preclinical and clinical studies on GDEPT.
  • Analysis of various enzyme-prodrug systems.
  • Discussion of targeting strategies and efficacy metrics.

Main Results:

  • Multiple enzyme-prodrug systems are under investigation.
  • Tumor specificity remains a key challenge.
  • Bystander effects show promise for improving treatment outcomes.

Conclusions:

  • GDEPT is a promising strategy for targeted cancer therapy.
  • Further research is needed to optimize tumor targeting and efficacy.
  • The development of effective enzyme-prodrug combinations holds significant therapeutic potential.

More Related Videos

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...